Location History:
- Oceanside, CA (US) (2009)
- Carlsbad, CA (US) (2004 - 2013)
- Encinitas, CA (US) (2014 - 2024)
Company Filing History:
4 out of 1,035 
2 out of 271 
1 out of 2,198 Years Active: 2004-2024
Title: The Innovative Mind of Lloyd G. Tillman
Introduction
Lloyd G. Tillman, based in Oceanside, California, is a distinguished inventor renowned for his contributions to the field of antisense oligonucleotide compositions. With an impressive portfolio of seven patents, Tillman has made significant strides in the biotechnology arena. His work focuses on developing compositions that enhance the functionality of antisense oligonucleotides, which are crucial in therapeutic applications.
Latest Patents
Among Tillman's most recent patents are methodologies and formulations involving antisense oligonucleotide compositions. These innovative compositions incorporate one or more excipients that modulate viscosity, turbidity, or both. For example, certain embodiments disclose compositions that utilize low viscosity excipients or low turbidity excipients. Furthermore, his work includes formulations aimed at producing pharmaceutical compositions that exhibit both low viscosity and turbidity, enhancing the overall therapeutic efficacy of these oligonucleotide products.
Career Highlights
Throughout his career, Lloyd G. Tillman has made considerable contributions while working with prominent companies such as Isis Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc. His expertise and innovative spirit have established him as a key figure in the development of cutting-edge biopharmaceutical technologies. His patents not only reflect his ingenuity but also his commitment to advancing scientific research and development in the field.
Collaborations
In addition to his own accomplishments, Tillman has collaborated with several notable colleagues, including Gregory E. Hardee and Ching-Leou Teng. These professional partnerships have enabled the sharing of knowledge and ideas, further driving innovation and enhancing the outcomes of their collective research endeavors.
Conclusion
Lloyd G. Tillman's work exemplifies the spirit of innovation in the biotechnology field. With his seven patents focused on antisense oligonucleotide compositions, he has significantly contributed to the advancement of therapeutic options. As he continues to push the boundaries of scientific research, his legacy as an influential inventor in the realm of biopharmaceuticals is firmly established.